Spotlight On... TrapX Labs details evolution of hospital network hackers; Intermountain docs use 3-D printed kidney to determine treatment; Elekta launches novel cervical cancer treatment device; and more...

TrapX Labs has released a new report detailing how hackers are evolving to penetrate hospital networks' cybersecurity. They are increasingly targeting medical devices that use operating systems with known vulnerabilities, and by hiding old malware into "new techniques," hackers can get past traditional security mechanisms and access hospital networks and the data they contain. Release

> Doctors at Utah's Intermountain Medical Center 3-D printed a model of a patient's kidney to help them decide how best to remove her tumor. Release

> Elekta ($EKTA) will introduce Venezia, a gynecological applicator for the treatment for advanced cervical cancer, at the World Congress of Brachytherapy. The device allows physicians an easy way to reach tumors using a combination of straight and oblique needles. Release

> The FDA granted priority review to Advanced Accelerator Applications' ($AAAP) Lutathera for the treatment of certain neuroendocrine tumors. Release

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.